Clients & Friends,
Looking back on 2025, one word comes to mind: resiliency. The life sciences sector has taken some hits, but it kept moving. Public markets are showing real signs of life again. The private side - frozen at times - is beginning to thaw. Investors are stepping back in, deals are returning and companies that spent two years tightening their belts are coming to market with a clearer sense of purpose. It’s a welcome shift that appears to be rewarding those who remained patient.
Please see full publication below for more information.
